Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells

Cell Death & Disease, Published online: 10 November 2021; doi:10.1038/s41419-021-04371-7Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells

Source: Cell death and disease - November 10, 2021 Category: Internal Medicine Authors: Tapas Patra Keith Meyer Ratna B. Ray Tatsuo Kanda Ranjit Ray Source Type: research